ATProto Browser

Record data

{
  "uri": "at://did:plc:5mbz5pb7xo2o5eef3xeixvgu/app.bsky.feed.post/3lolj2iints2d",
  "cid": "bafyreigbpekfakyfbw6atm3p7pn6yuovspieefmpzkohgds4tw22yyc7i4",
  "value": {
    "text": "On new CBER Director Vinay Prasad: His comments on vaccines and other public health measures led some to question whether he is committed to upholding sound science and regulatory policy or is more interested in pushing contrarian views for attention and political influence.  #healthpolicy #biosky",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/tougher-approval-standards-may-follow-vinay-prasads-appointment-to-lead-us-fdas-cber-WEULXI5EJRE43BWU752PGDGE44/",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreienzhsh3jity6fyzr75mkvlyyngwk7gijm3hpatihaihgqvl352h4"
          },
          "mimeType": "image/jpeg",
          "size": 829135
        },
        "title": "Tougher Approval Standards May Follow Vinay Prasad’s Appointment To Lead US FDA’s CBER",
        "description": "Industry is concerned that Prasad may make regulatory flexibility tougher to obtain for cell and gene therapy, while vaccine and public health advocates are angry about Prasad’s criticisms of US COVID..."
      }
    },
    "langs": [
      "en"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 290,
          "byteStart": 277
        },
        "features": [
          {
            "tag": "healthpolicy",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 298,
          "byteStart": 291
        },
        "features": [
          {
            "tag": "biosky",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      }
    ],
    "createdAt": "2025-05-07T13:31:41.747Z"
  }
}